373 related articles for article (PubMed ID: 12563135)
1. Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors.
Gervais DA; McGovern FJ; Arellano RS; McDougal WS; Mueller PR
Radiology; 2003 Feb; 226(2):417-24. PubMed ID: 12563135
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes.
Ahrar K; Matin S; Wood CG; Wallace MJ; Gupta S; Madoff DC; Rao S; Tannir NM; Jonasch E; Pisters LL; Rozner MA; Kennamer DL; Hicks ME
J Vasc Interv Radiol; 2005 May; 16(5):679-88. PubMed ID: 15872323
[TBL] [Abstract][Full Text] [Related]
3. Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas.
McClure TD; Chow DS; Tan N; Sayre JA; Pantuck AJ; Raman SS
J Vasc Interv Radiol; 2014 Nov; 25(11):1682-8; quiz 1689. PubMed ID: 25081202
[TBL] [Abstract][Full Text] [Related]
4. Image-Guided Percutaneous Radiofrequency Ablation of Central Renal Cell Carcinoma: Assessment of Clinical Efficacy and Safety in 31 Tumors.
Dai Y; Covarrubias D; Uppot R; Arellano RS
J Vasc Interv Radiol; 2017 Dec; 28(12):1643-1650. PubMed ID: 28673657
[TBL] [Abstract][Full Text] [Related]
5. Renal tumors: technical success and early clinical experience with radiofrequency ablation of 18 tumors.
Sabharwal R; Vladica P
Cardiovasc Intervent Radiol; 2006; 29(2):202-9. PubMed ID: 16447001
[TBL] [Abstract][Full Text] [Related]
6. CT-guided bipolar and multipolar radiofrequency ablation (RF ablation) of renal cell carcinoma: specific technical aspects and clinical results.
Sommer CM; Lemm G; Hohenstein E; Bellemann N; Stampfl U; Goezen AS; Rassweiler J; Kauczor HU; Radeleff BA; Pereira PL
Cardiovasc Intervent Radiol; 2013 Jun; 36(3):731-7. PubMed ID: 22926302
[TBL] [Abstract][Full Text] [Related]
7. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas.
Zagoria RJ; Traver MA; Werle DM; Perini M; Hayasaka S; Clark PE
AJR Am J Roentgenol; 2007 Aug; 189(2):429-36. PubMed ID: 17646471
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours.
Wah TM; Irving HC; Gregory W; Cartledge J; Joyce AD; Selby PJ
BJU Int; 2014 Mar; 113(3):416-28. PubMed ID: 24053769
[TBL] [Abstract][Full Text] [Related]
9. Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response?
Kong WT; Zhang WW; Guo HQ; Qiu JL; Tang M; Jiang ZM; Shen Y; Li XG; Zhang SW
Abdom Imaging; 2011 Jun; 36(3):342-7. PubMed ID: 21107560
[TBL] [Abstract][Full Text] [Related]
10. Radiofrequency ablation combined with renal arterial embolization for the treatment of unresectable renal cell carcinoma larger than 3.5 cm: initial experience.
Yamakado K; Nakatsuka A; Kobayashi S; Akeboshi M; Takaki H; Kariya Z; Kinbara H; Arima K; Yanagawa M; Hori Y; Kato H; Sugimura Y; Takeda K
Cardiovasc Intervent Radiol; 2006; 29(3):389-94. PubMed ID: 16502180
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
Zhou W; Uppot RN; Feldman AS; Arellano RS
AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
[TBL] [Abstract][Full Text] [Related]
12. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors.
Gervais DA; McGovern FJ; Arellano RS; McDougal WS; Mueller PR
AJR Am J Roentgenol; 2005 Jul; 185(1):64-71. PubMed ID: 15972400
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous radiofrequency ablation of renal tumors: midterm results in 16 patients.
Memarsadeghi M; Schmook T; Remzi M; Weber M; Pötscher G; Lammer J; Kettenbach J
Eur J Radiol; 2006 Aug; 59(2):183-9. PubMed ID: 16725292
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease.
Xu L; Rong Y; Wang W; Lian H; Gan W; Yan X; Li X; Guo H
World J Surg Oncol; 2016 Jul; 14(1):193. PubMed ID: 27460786
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C
Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment.
Wells SA; Wheeler KM; Mithqal A; Patel MS; Brace CL; Schenkman NS
Abdom Radiol (NY); 2016 Jun; 41(6):1203-11. PubMed ID: 27167230
[TBL] [Abstract][Full Text] [Related]
17. Experiences in US-guided percutaneous radiofrequency ablation of 44 renal tumors in 31 patients: analysis of predictors for complications and technical success.
Veltri A; Calvo A; Tosetti I; Pagano E; Genovesio A; Virzì V; Ferrando U; Fontana D; Gandini G
Cardiovasc Intervent Radiol; 2006; 29(5):811-8. PubMed ID: 16832595
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous radio frequency ablation of renal tumors in patients with von Hippel-Lindau disease: preliminary results.
Park BK; Kim CK
J Urol; 2010 May; 183(5):1703-7. PubMed ID: 20299060
[TBL] [Abstract][Full Text] [Related]
19. Chyluria after radiofrequency ablation of renal tumors.
Kaur H; Matin SF; Javadi S; Johnson VE; Choi H; Sandler C; Ahrar K
J Vasc Interv Radiol; 2011 Jul; 22(7):924-7. PubMed ID: 21507680
[TBL] [Abstract][Full Text] [Related]
20. US-guided percutaneous microwave ablation of renal cell carcinoma: intermediate-term results.
Yu J; Liang P; Yu XL; Cheng ZG; Han ZY; Mu MJ; Wang XH
Radiology; 2012 Jun; 263(3):900-8. PubMed ID: 22495684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
